Order Article Reprints

Hirschberg S, Ghazaani F, Ben Amor G, Pydde M, Nagel A, Germani S, Monica L, Schlör A, Bauer H, Hornung J, et al. An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line. Vaccines. 2023; 11(9):1469. https://doi.org/10.3390/vaccines11091469

Hirschberg, Stefan, Fatemeh Ghazaani, Ghada Ben Amor, Markus Pydde, Alexander Nagel, Saveria Germani, Lara Monica, Anja Schlör, Hannes Bauer, Jane Hornung, and et al. 2023. "An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line" Vaccines 11, no. 9: 1469. https://doi.org/10.3390/vaccines11091469

Hirschberg, S., Ghazaani, F., Ben Amor, G., Pydde, M., Nagel, A., Germani, S., Monica, L., Schlör, A., Bauer, H., Hornung, J., Voetz, M., Dwai, Y., Scheer, B., Ringel, F., Kamal-Eddin, O., Harms, C., Füner, J., Adrian, L., Pruß, A., ... Kamhieh-Milz, J. (2023). An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line. Vaccines, 11(9), 1469. https://doi.org/10.3390/vaccines11091469